Key Insights

Highlights

Treatment Research

2 treatments under study, led by Nicotine Mint Oro Dispersible Tablet Nic Odt

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07893158Phase 2Recruiting

A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers

Showing all 1 trials

Research Network

Common Treatments

  • Nicotine Mint Oro Dispersible Tablet Nic Odt1
  • Placebo Oro Dispersible Tablet Placebo Odt1

Active Sponsors

  • Mcneil Ab1

Related Conditions

  • Smoking Cessation1

Activity Timeline